Canopy FGF signaling regulator 3 affects prognosis, immune infiltration, and PI3K/AKT pathway in colon adenocarcinoma

doi:10.4251/wjgo.v16.i7.3284

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (223)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

HTML

132

Figures (1-6)

Sum=158

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=49

Publishing Process of This Article

Item

Count

Browse

Download

Sum=8

Jul 15, 2024 (publication date) through Jul 15, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3284-3298
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3284

Full Size Figure Download Figure

Figure 4 Functional enrichment analysis. A: Top 50 differently expressed genes (DEGs); B: Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis of DEGs; C: Gene Set Enrichment Analysis enrichment analysis. BP: Biological process; CC: Cellular component; MF: Molecular function; KEGG: Kyoto Encyclopedia of Genes and Genomes.

Citation: Gao XC, Zhou BH, Ji ZX, Li Q, Liu HN. Canopy FGF signaling regulator 3 affects prognosis, immune infiltration, and PI3K/AKT pathway in colon adenocarcinoma. World J Gastrointest Oncol 2024; 16(7): 3284-3298
URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3284.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3284